Literature DB >> 15331438

Molecular characterization of early human T/NK and B-lymphoid progenitor cells in umbilical cord blood.

Rima Haddad1, Philippe Guardiola, Brigitte Izac, Christelle Thibault, Jerry Radich, Anne-Lise Delezoide, Claude Baillou, François M Lemoine, Jean Claude Gluckman, Françoise Pflumio, Bruno Canque.   

Abstract

The early stages of human lymphopoiesis are poorly characterized. Here, we compared the lymphoid potential of a novel umbilical cord blood CD34(+)CD45RA(hi)CD7(+) hematopoietic progenitor cell (HPC) population with that of CD34(+)CD45RA(hi)Lin(-)CD10(+) HPCs, previously proposed as candidate common lymphoid progenitors. Limiting-dilution and clonal analysis, fetal thymic organ cultures, and culture onto Notch ligand Delta-like-1-expressing OP9 cells, showed that although CD34(+)CD45RA(hi)CD7(+) HPCs could generate cells of the 3 lymphoid lineages, their potential was skewed toward the T/natural killer (T/NK) lineages. In contrast, CD34(+)CD45RA(hi)Lin(-)CD10(+) HPCs predominantly exhibited a B-cell potential. Gene expression profiling with DNA microarrays confirmed that CD34(+)CD45RA(hi)CD7(+) HPCs selectively expressed T-lymphoid and NK lineage-committed genes while retaining expression of genes affiliated to the granulomonocytic lineage, whereas CD34(+)CD45RA(hi)Lin(-)CD10(+) HPCs displayed a typical pro-B-cell transcription profile and essentially lacked genes unrelated to the B lineage. In addition, both populations could be generated in vitro from CD34(+)CD45RA(int)CD7(-) and CD34(+)CD45RA(hi)Lin(-) HPCs with mixed lymphomyeloid potential, from which they emerged independently with different growth/differentiation factor requirements. These findings indicate that CD34(+)CD45RA(hi)CD7(+) and CD34(+)CD45RA(hi)Lin(-)CD10(+) HPCs correspond to multipotent early lymphoid progenitors polarized toward either the T/NK or B lineage, respectively.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331438     DOI: 10.1182/blood-2004-05-1845

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  42 in total

Review 1.  Generation of natural killer cells from hematopoietic stem cells in vitro for immunotherapy.

Authors:  Martha Luevano; Alejandro Madrigal; Aurore Saudemont
Journal:  Cell Mol Immunol       Date:  2012-06-18       Impact factor: 11.530

2.  Development of a diverse human T-cell repertoire despite stringent restriction of hematopoietic clonality in the thymus.

Authors:  Martijn H Brugman; Anna-Sophia Wiekmeijer; Marja van Eggermond; Ingrid Wolvers-Tettero; Anton W Langerak; Edwin F E de Haas; Leonid V Bystrykh; Jon J van Rood; Gerald de Haan; Willem E Fibbe; Frank J T Staal
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-19       Impact factor: 11.205

3.  Human Intestinal Allografts Contain Functional Hematopoietic Stem and Progenitor Cells that Are Maintained by a Circulating Pool.

Authors:  Jianing Fu; Julien Zuber; Mercedes Martinez; Brittany Shonts; Aleksandar Obradovic; Hui Wang; Sai-Ping Lau; Amy Xia; Elizabeth E Waffarn; Kristjana Frangaj; Thomas M Savage; Michael T Simpson; Suxiao Yang; Xinzheng V Guo; Michelle Miron; Takashi Senda; Kortney Rogers; Adeeb Rahman; Siu-Hong Ho; Yufeng Shen; Adam Griesemer; Donna L Farber; Tomoaki Kato; Megan Sykes
Journal:  Cell Stem Cell       Date:  2018-11-29       Impact factor: 24.633

4.  Transcriptome profiling of peripheral blood immune cell populations in multiple sclerosis patients before and during treatment with a sphingosine-1-phosphate receptor modulator.

Authors:  Ines C Angerer; Michael Hecker; Dirk Koczan; Luisa Roch; Jörg Friess; Annelen Rüge; Brit Fitzner; Nina Boxberger; Ina Schröder; Kristin Flechtner; Hans-Jürgen Thiesen; Alexander Winkelmann; Stefanie Meister; Uwe K Zettl
Journal:  CNS Neurosci Ther       Date:  2018-01-03       Impact factor: 5.243

5.  Generation of functional natural killer and dendritic cells in a human stromal-based serum-free culture system designed for cord blood expansion.

Authors:  Ana M Frias; Christopher D Porada; Kirsten B Crapnell; Joaquim M S Cabral; Esmail D Zanjani; Graça Almeida-Porada
Journal:  Exp Hematol       Date:  2008-01       Impact factor: 3.084

6.  Shortening the immunodeficient period after hematopoietic stem cell transplantation.

Authors:  Isabelle André-Schmutz; Emmanuelle Six; Delphine Bonhomme; Julien Rouiller; Liliane Dal Cortivo; Alain Fischer; Marina Cavazzana-Calvo
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

Review 7.  The long road to the thymus: the generation, mobilization, and circulation of T-cell progenitors in mouse and man.

Authors:  Daniel A Zlotoff; Benjamin A Schwarz; Avinash Bhandoola
Journal:  Semin Immunopathol       Date:  2008-10-17       Impact factor: 9.623

8.  Human proT-cells generated in vitro facilitate hematopoietic stem cell-derived T-lymphopoiesis in vivo and restore thymic architecture.

Authors:  Génève Awong; Jastaranpreet Singh; Mahmood Mohtashami; Maria Malm; Ross N La Motte-Mohs; Patricia M Benveniste; Pablo Serra; Elaine Herer; Marcel R van den Brink; Juan Carlos Zúñiga-Pflücker
Journal:  Blood       Date:  2013-11-08       Impact factor: 22.113

9.  Efficient retroviral transduction of human B-lymphoid and myeloid progenitors: marked inhibition of their growth by the Pax5 transgene.

Authors:  Rieko Sekine; Toshio Kitamura; Takashi Tsuji; Arinobu Tojo
Journal:  Int J Hematol       Date:  2008-05       Impact factor: 2.490

10.  Transcriptional profiling reveals developmental relationship and distinct biological functions of CD16+ and CD16- monocyte subsets.

Authors:  Petronela Ancuta; Kuang-Yu Liu; Vikas Misra; Vanessa Sue Wacleche; Annie Gosselin; Xiaobo Zhou; Dana Gabuzda
Journal:  BMC Genomics       Date:  2009-08-27       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.